The value of CD8⁺T cells from tumor biopsy in early prediction of the efficacy and prognosis of neoadjuvant chemotherapy for osteosarcomaGUO Haoyu, PENG Xiuqing, LUO Yuejun et al.Chinese Clinical Oncology2025, No.12002026-01The relationship between PET/CT metabolic heterogeneity of primary lesions and metastatic lymph nodes in stage Ⅲnon-small cell lung cancer and the efficacy of radiotherapy and chemotherapyDENG Lixia, ZHAO Qinglian, LIU Sukun et al.Chinese Clinical Oncology2025, No.12002026-01Clinical efficacy and prognostic factors of repeated hepatectomy/ablation adjuvant transcatheter arterial chemoembolization in patients with early recurrence of hepatocellular carcinomaWANG Chu, LIU Donghui, JIN Gang et al.Chinese Clinical Oncology2025, No.12002026-01Research progress on the combination of PARP inhibitors and ferroptosis in ovarian cancerWANG Xuening, NI Jing, YE Luxin et al.Chinese Clinical Oncology2025, No.12002026-01Application research of labial suture combined with C-type tunnel extraperitoneal fistula in laparoscopic miles surgery for rectal cancerSONG Mo, LI Yun, XI Shanshan et al.Chinese Clinical Oncology2025, No.12002026-01Experimental study on the effect of apolipoprotein D expression on the biological behavior of cervical squamous cell carcinoma cellsGONG Jun, SHI Xiaohui, LUO JuanChinese Clinical Oncology2025, No.12002026-01Comparison of the therapeutic effects between endoscopic and open modified radical mastectomy for breast cancerSPU Zhuo, ZHAO Xiaobo, ZHOU ShuangChinese Clinical Oncology2025, No.12002026-01Study on the clinicopathological characteristics and prognosis of breast cancer with HER-2 low expressionJIANG Jianping, LUO Xiangrong, YAN Xuebo et al.Chinese Clinical Oncology2025, No.12002026-01The diagnostic value of ultrasound elastography parameters combined with serum MMP-9,VEGF,and sIL-2R for lymph node metastasis in thyroid cancerLI Zhi, LIANG Renjie, Qin ShaojieChinese Clinical Oncology2025, No.11002026-01Mechanism of inhibitory effect of sodium aescinate on the proliferation and migration of nasopharyngeal carcinoma cells via Keap1/Nrf2/HO-1 signaling pathwayYIN Xiuwen, BAO Yongzheng, HU Zhibang et al.Chinese Clinical Oncology2025, No.11002026-01The relationship between immune cell infiltration density in tumor parenchyma and stroma and postoperative prognosis of gastric cancerZHU Wen, LI Xiaoqin, TAO Qing et al.Chinese Clinical Oncology2025, No.11002026-01Effects of plumbagin on the growth,invasion and apoptosis of gastric cancer cells by regulating the expression of HIF-1αLI Xin, WANG Shouxing, LIU Yuangang et al.Chinese Clinical Oncology2025, No.11002026-01Expression of F-box only protein 21 in clear cell renal cell carcinoma and its association with prognosis and immune infiltrationCAI Yangke, JIANG Huiming, PENG Dong et al.Chinese Clinical Oncology2025, No.11002026-01Correlation study on the expression of TFCP2L1,DUSP26,and MLKL proteins in differentiated thyroid cancer with clinicopathological characteristics and the efficacy of iodine therapyWANG Jian, LIU Haiyang, ZHANG Xuemei et al.Chinese Clinical Oncology2025, No.11002026-01Efficacy of TC regimen plus bevacizumab combined with olaparib in the treatment of advanced ovarian cancer and its effect on immune functionZHANG Can, CHEN Lei, YIN Yi et al.Chinese Clinical Oncology2025, No.11002026-01Assessment of safety and feasibility of allogeneic NKG2DL-specific CAR-NK cells in patients with relapsed or refractory acute myeloid leukemiaYANG Yuanlin, FEI Xiaoming, LEI Fang et al.Chinese Clinical Oncology2025, No.11002026-01Experimental study on the regulation of proliferation,apoptosis,and 5-FU sensitivity in gastric cancer cells by plumbagin through the PI3K/AKT/mTOR pathwayXU Mingxing, JIANG HongmeiChinese Clinical Oncology2025, No.11002026-01Prognostic value and immune infiltration analysis of RCSD domain-containing protein 1 in non-small cell lung cancerMENG Deming, JIA Jiang, ZHANG Qian et al.Chinese Clinical Oncology2025, No.11002026-01The impacts of LncRNA OIP5-AS1 on the proliferation,migration and invasion of papillary thyroid carcinoma cells by modulating the miR-410-3p/MYH9 axisZHANG Menglei, YANG Longfei, WANG NaChinese Clinical Oncology2025, No.11002026-01The application and research progress of patient-reported outcomes in oncology drug clinical trialsWANG Yongqi, YANG Funa, LIU Yanyan et al.Chinese Clinical Oncology2025, No.11002026-01 